Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Giriraj Singh Inaugurates ‘Weave The Future 5.0’, Unveils Visvakarma Gallery at Re-envisioned Handloom Haat Lifestyle
  • Rajashree Deshpande Won the title of Mrs Maharashtra Timeless Beauty in Diva Pageant 2023 Lifestyle
  • Fanly Entertainment Gets a Glittering Launch by Sivakarthikeyan & Other Celebrities Business
  • Malabar Gold & Diamonds Offers 100% Exchange Value When Upgrading Old Malabar Diamond Jewellery for New Gold and Diamond Jewellery Business
  • New Age production house IdeaRack enters OTT space with Runaway Lugaai for MX Player, stars Sanjay Mishra, Naveen Kasturia English
  • Over 20 countries to Showcase over 5000 Products and Technologies at Didac India in Delhi Business
  • Harvesting Dignity, Delivering Freshness: DailyGurus Builds a New Agri-Economy for India’s Villages Business
  • Lafayette | Sonani Diamond Jewellery Boutique Launched at The Tivoli Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • An advanced ‘Pediatric Clinic’ launched in Gurgaon offers a gamut of pediatric services under one roof Health
  • Virulina: Patent-Awarded Polyherbal Breakthrough for Viral Respiratory Infection and Immunomodulatory Conditions Health
  • Welex Care Strengthens Its Commitment to Natural, Safe Health Care Solutions Health
  • IVF Treatment in India: How Much Does it Cost Health
  • The Impact of Climate Change on Child Health Health
  • Medilinks India’s South Asia Pacific Healthcare Summit & Business Awards 2020 held Successfully in Delhi, felicitated Healthcare Dignitaries Business

Recent Posts

  • ixigo Launches ‘Smart Lock’ – An Agentic AI That Autonomously Monitors and Locks Flight Fares Within Your Budget
  • Yugality: India’s First Legal Ecosystem Connecting Lawyers, Clients and Legal Work — All in One Place
  • Team Computers Strengthens Its Play in India’s GCC Boom, Backed by Apple’s Top Enterprise Partner Recognition
  • Haresh Sippy’s Living on the Edge: A Guide to Living to the Fullest Explores Life, Uncertainty and the Pursuit of Fulfillment
  • How Oncare Is Building a More Transparent & Affordable Model for Cancer Treatment in India

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Shahid, Nora, Malaika, Sunil Grover, Honey Singh to dazzle at Stardom 2024! Entertainment
  • Leading crypto currency YES WORLD is now accepted at Vending Machines and POS terminals worldwide Business
  • New opportunities ahead as Metropolitan University, College of Medicine offers up to 40% scholarships to NEET students Press Release
  • Colourmoon Technologies: Celebrating 15 Years of Innovation, Excellence, and Team Spirit Business
  • Royal Halls: The Ultimate Destination for Grand and Intimate Gatherings Lifestyle
  • India Has Solved Financial Access. Has It Solved Financial Confidence? Finance
  • Reliance Nippon Life Insurance Wins The Prestigious National Energy Conservation Awards (NECA) 2023, In The Corporate Office Sector Business
  • Shivalik Group Announces Launch of LOFY – Home Interior Solutions Business Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme